|[December 16, 2013]
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of NuPathe Inc. Stockholders
NEW YORK --(Business Wire)--
Kirby McInerney LLP is investigating potential claims against the Board
of Directors of NuPathe Inc. ("NuPathe" or the "Company") (NASDAQ: PATH)
concerning the proposed acquisition of the Company by Endo Health
Solutions Inc. ("Endo") (NASDAQ: ENDP). Under the terms of the
definitive merger agreement, NuPathe stockholders will receive $2.85 in
cash for each share of NuPathe owned, valuing the transaction at
approximately $105 million.
The investigation concerns whether the NuPathe Board of Directors
violated its fiduciary duties by agreeing to the proposed transaction
and whether the $2.85 per share propsed consideration adequately values
NuPathe's common stock.
If you are a NuPathe stockholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email at firstname.lastname@example.org,
by telephone at (212) 699-1145 or (888) 529-4787, or by filling
out this contact form. There is no cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating in
securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to www.kmllp.com.
[ Back To Technology News's Homepage ]